PI-1840
CAS: 1401223-22-0
Ref. 3D-BGC22322
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Product Information
Name:
PI-1840
Description:
PI-1840 is a small molecule that can inhibit the proteasome and thus induce cancer cell apoptosis. PI-1840 has been shown to be an inhibitor of the immunoproteasome, which is an enzyme involved in protein degradation. PI-1840 also sensitizes cancer cells to bortezomib, a drug that inhibits the proteasome. PI-1840 has been shown to be effective against human cancer cells in culture and has potential as an anticancer agent.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
394.47 g/mol
Formula:
C22H26N4O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-BGC22322 PI-1840
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
